Loading viewer...
earnings
Format: PDF earnings
Mesoblast presented financial results for the first quarter ended September 30, 2016. The presentation includes forward-looking statements regarding adult stem cell technology development, regulatory timelines, manufacturing processes, and partnerships with JCR Pharmaceuticals and Lonza. The company discusses capital requirements and business growth expectations in an evolving biotech landscape.
presentation
earnings
18 Pages
Glenmark Life Sciences
Millicom 2016 Q4 Results Earnings
earningsearnings
34 Pages
Millicom International Cellular S.A.
Brady Corporation Q2 2017 Earnings Results
earningsearnings
18 Pages
Brady Corporation
TCS Financial Results Q3 FY2017 Earnings
earningsearnings
28 Pages
Tata Consultancy Services